Coenzyme F420, helping mycobacteria find a niche in humans
辅酶 F420,帮助分枝杆菌在人类中找到一席之地
基本信息
- 批准号:10666639
- 负责人:
- 金额:$ 19.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAerobic BacteriaAnabolismAnaerobic BacteriaAnimalsAttentionAutophagocytosisBiochemical PathwayBiochemistryBiologyBiosynthetic ProteinsC3HeB/FeJ MouseClinicalCoenzymesDiseaseDrug ToleranceEnsureEnzymesEvolutionFlavinsFlavoproteinsFoundationsGeneticGenomeGenus MycobacteriumGoalsGranulomaGrowthHost DefenseHumanHypoxiaImmune EvasionImmune systemIn VitroInfectionInternationalInterventionLesionLife StyleLinkM. tuberculosis genomeMacrophageMetabolicMetabolismModelingMorbidity - disease rateMycobacterium lepraeMycobacterium smegmatisMycobacterium tuberculosisNecrosisNiacinamideNitroimidazolesOrganOxidation-ReductionOxidative StressOxygenPathogenesisPathologyPathway interactionsPharmaceutical PreparationsPhysiologyPlayPoint MutationPredispositionProdrugsProductionProtein BiochemistryProteinsReactionResearchResearch PersonnelRoleS-AdenosylhomocysteineS-AdenosylmethionineStressStructureSystemTimeTuberculosisbiochemical toolschromophorecofactorenvironmental stressorexperienceimprovedin vitro Modelinsightknock-downlatent infectionmetabolomicsmicroorganismmortalitymouse modelmutantmycobacterialnitrosative stresspathogenprogramsstructural biologytranscriptomicstuberculosis treatment
项目摘要
Project summary
Mycobacterium tuberculosis, the causative agent of TB, remains an important cause of morbidity and mortality
worldwide. Persistence in hypoxic conditions within granuloma is the hallmark of TB, leading to latent infection
and limiting the application of current therapies. Understanding how M. tuberculosis supports its metabolism
under hypoxic conditions, and adapts to these challenges, is key to eliminating latent TB. “Disarming” M.
tuberculosis by removing its ability to endure the stress-inducing conditions in granuloma will provide a feasible
strategy for clinical interventions against latent TB.
We will investigate the role of the coenzyme F420 in the physiology and pathogenesis of M. tuberculosis. F420 is
a deazaflavin that acts as a carrier in a wide range of hydride transfer reactions. Growing evidence points to the
wide use of this cofactor by M. tuberculosis, with its low redox potential thought to give it key roles in hypoxic
persistence. There appears to be F420-dependent mechanisms in mycobacteria that are used to protect against
oxidative and nitrosative stress, but the contribution of F420 to M. tuberculosis metabolism and persistence
remains unclear. The ultimate goal of the project is to investigate how F420 facilitates M. tuberculosis’ survival
under hypoxic conditions within granuloma, elucidating its role in persistence. We have devised an integrated
experimental approach using genetics, metabolomics, animal infection models, and protein biochemistry tools
to determine how F420 helps M. tuberculosis persist during pathogenesis. We will construct a set of conditional
knockdown strains targeting F420 biosynthesis and metabolism, and perform in vitro studies to determine how M.
tuberculosis utilizes F420 under hypoxic conditions and during re-growth after hypoxia-induced dormancy. We will
then perform infection studies in a mouse model that develops necrotic and hypoxic TB lesions to investigate
how F420 facilitates M. tuberculosis survival inside granuloma and to understand the link between F420 and
persistence. Finally, we will reveal structural insights into the biosynthesis of F420 chromophore, providing the
foundations for mechanistic and inhibition studies of this essential reaction in F420 biosynthesis.
项目概要
结核分枝杆菌是结核病的病原体,仍然是发病和死亡的重要原因
在世界范围内, oma 内持续存在颗粒缺氧状况是结核病的标志,导致潜伏感染。
并限制当前疗法的应用。了解结核分枝杆菌如何支持其代谢。
在缺氧条件下并适应这些挑战是消除潜在结核病“解除武装”的关键。
通过消除其耐受肉芽肿中应激条件的能力来治疗结核病将提供一种可行的方法
针对潜伏性结核病的临床干预策略。
我们将研究辅酶 F420 在结核分枝杆菌 F420 的生理学和发病机制中的作用。
越来越多的证据表明,脱氮黄素在多种氢化物转移反应中充当载体。
结核分枝杆菌广泛使用这种辅助因子,其氧化还原电位低,被认为使其在缺氧中发挥关键作用
分枝杆菌中似乎存在 F420 依赖性机制,可用于预防。
氧化和亚硝化应激,但 F420 对结核分枝杆菌代谢和持久性的贡献
目前尚不清楚该项目的最终目标是研究 F420 如何促进结核分枝杆菌的存活。
在肉芽肿内的缺氧条件下,阐明其在持久性中的作用我们设计了一种综合方法。
使用遗传学、代谢组学、动物感染模型和蛋白质生物化学工具的实验方法
为了确定 F420 如何帮助结核分枝杆菌在发病过程中持续存在,我们将构建一组条件。
针对 F420 生物合成和代谢的敲低菌株,并进行体外研究以确定 M.
结核病在缺氧条件下和缺氧诱导休眠后的重新生长过程中利用F420。
然后在出现坏死和缺氧结核病灶的小鼠模型中进行感染研究以进行调查
F420 如何促进结核分枝杆菌在肉芽肿内存活并了解 F420 与结核分枝杆菌之间的联系
最后,我们将揭示 F420 发色团生物合成的结构见解,提供
F420 生物合成中这一重要反应的机理和抑制研究奠定了基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Berney其他文献
Michael Berney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Berney', 18)}}的其他基金
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
通过高通量代谢分析鉴定结核分枝杆菌基本功能的新抑制剂
- 批准号:
10568482 - 财政年份:2022
- 资助金额:
$ 19.8万 - 项目类别:
Coenzyme F420, helping mycobacteria find a niche in humans
辅酶 F420,帮助分枝杆菌在人类中找到一席之地
- 批准号:
10528305 - 财政年份:2022
- 资助金额:
$ 19.8万 - 项目类别:
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
通过终末呼吸氧化酶的合成致死作用根除持续存在的结核分枝杆菌
- 批准号:
10509390 - 财政年份:2018
- 资助金额:
$ 19.8万 - 项目类别:
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
通过终末呼吸氧化酶的合成致死作用根除持续存在的结核分枝杆菌
- 批准号:
10295045 - 财政年份:2018
- 资助金额:
$ 19.8万 - 项目类别:
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
通过终末呼吸氧化酶的合成致死作用根除持续存在的结核分枝杆菌
- 批准号:
10053706 - 财政年份:2018
- 资助金额:
$ 19.8万 - 项目类别:
Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis.
抑制蛋氨酸生物合成可以消除持续存在的结核分枝杆菌。
- 批准号:
9214311 - 财政年份:2016
- 资助金额:
$ 19.8万 - 项目类别:
Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis.
抑制蛋氨酸生物合成可以消除持续存在的结核分枝杆菌。
- 批准号:
9111579 - 财政年份:2016
- 资助金额:
$ 19.8万 - 项目类别:
相似海外基金
Coenzyme F420, helping mycobacteria find a niche in humans
辅酶 F420,帮助分枝杆菌在人类中找到一席之地
- 批准号:
10528305 - 财政年份:2022
- 资助金额:
$ 19.8万 - 项目类别:
Minority Student Development Program at Northern Arizona University
北亚利桑那大学少数民族学生发展计划
- 批准号:
7214789 - 财政年份:1998
- 资助金额:
$ 19.8万 - 项目类别:
Minority Student Development Program at Northern Arizona University
北亚利桑那大学少数民族学生发展计划
- 批准号:
7428796 - 财政年份:1998
- 资助金额:
$ 19.8万 - 项目类别: